Regulatory, Compliance, and
More.Abstract
Objective: Cervical cancer remains a significant global health challenge [1], particularly in patients with comorbidities such as HIV, diabetes mellitus, obesity, and hypertension, which exacerbate systemic inflammation and complicate care [2,3]. This study evaluates the impact of comprehensive comorbidity management frameworkâencompassing antiretroviral therapy (ART), glycemic control, weight management, and antihypertensive interventions, -on overall survival (OS) and overall response rate (ORR) [4,5].